Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2006 1
2009 1
2011 2
2012 3
2014 1
2018 1
2020 3
2021 3
2022 2
2023 2
2024 1

Text availability

Article attribute

Article type

Publication date

Search Results

18 results

Results by year

Filters applied: . Clear all
Page 1
Comparisons of unmanipulated haploidentical donor, unrelated cord blood donor and matched unrelated donor hematopoietic stem cell transplantation in pediatric acquired severe aplastic anemia: a single center study.
Lu Y, Xiong M, Sun RJ, Zhang JP, Zhao YL, Wei ZJ, Cao XY, Zhou JR, Liu DY, Lu DP. Lu Y, et al. Among authors: zhou jr. Leuk Lymphoma. 2022 Dec;63(14):3307-3316. doi: 10.1080/10428194.2022.2118527. Epub 2022 Sep 6. Leuk Lymphoma. 2022. PMID: 36067518
Comparable outcomes among unmanipulated haploidentical, matched unrelated, and matched sibling donors in BU-based myeloablative hematopoietic stem cell transplantation for intermediate and adverse risk acute myeloid leukemia in complete remission: a single-center study.
Lu Y, Zhao YL, Zhang JP, Xiong M, Cao XY, Liu DY, Sun RJ, Wei ZJ, Zhou JR, Lu DP. Lu Y, et al. Among authors: zhou jr. Ann Hematol. 2021 Jun;100(6):1579-1591. doi: 10.1007/s00277-020-04355-1. Epub 2020 Nov 24. Ann Hematol. 2021. PMID: 33236196
Integrating CAR T-Cell Therapy and Transplantation: Comparisons of Safety and Long-Term Efficacy of Allogeneic Hematopoietic Stem Cell Transplantation After CAR T-Cell or Chemotherapy-Based Complete Remission in B-Cell Acute Lymphoblastic Leukemia.
Zhao YL, Liu DY, Sun RJ, Zhang JP, Zhou JR, Wei ZJ, Xiong M, Cao XY, Lu Y, Yang JF, Zhang X, Lu DP, Lu P. Zhao YL, et al. Among authors: zhou jr. Front Immunol. 2021 May 7;12:605766. doi: 10.3389/fimmu.2021.605766. eCollection 2021. Front Immunol. 2021. PMID: 34025637 Free PMC article.
Prognostic factors of second hematopoietic allogeneic stem cell transplantation among hematological malignancy patients relapsed after first hematopoietic stem cell transplantation: A single center study.
Lu Y, Zhang JP, Zhao YL, Xiong M, Sun RJ, Cao XY, Wei ZJ, Zhou JR, Liu DY, Yang JF, Zhang X, Lu DP, Lu P. Lu Y, et al. Among authors: zhou jr. Front Immunol. 2023 Jan 4;13:1066748. doi: 10.3389/fimmu.2022.1066748. eCollection 2022. Front Immunol. 2023. PMID: 36685540 Free PMC article.
A safety and efficacy study of allogeneic haematopoietic stem cell transplantation for refractory and relapsed T-cell acute lymphoblastic leukaemia/lymphoblastic lymphoma patients who achieved complete remission after autologous CD7 chimeric antigen receptor T-cell therapy.
Cao XY, Zhang JP, Lu Y, Zhao YL, Liu DY, Xiong M, Sun RJ, Wei ZJ, Zhou JR, Zhang X, Yang JF, Li J, Lu P. Cao XY, et al. Among authors: zhou jr. Br J Haematol. 2024 Apr 13. doi: 10.1111/bjh.19445. Online ahead of print. Br J Haematol. 2024. PMID: 38613241
Unmanipulated Haploidentical Hematopoietic Stem Cell Transplantation Achieved Outcomes Comparable With Matched Unrelated Donor Transplantation in Young Acquired Severe Aplastic Anemia.
Lu Y, Sun RJ, Zhao YL, Xiong M, Cao XY, Zhang JP, Wei ZJ, Zhou JR, Liu DY, Lu DP. Lu Y, et al. Among authors: zhou jr. Biol Blood Marrow Transplant. 2018 Sep;24(9):1881-1887. doi: 10.1016/j.bbmt.2018.05.015. Epub 2018 May 14. Biol Blood Marrow Transplant. 2018. PMID: 29772350 Free article.
18 results